Diagnostic potential of mannose binding lectin (MBL) gene polymorphism in rheumatoid arthritis patients

Cross, 2014, The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study, Ann Rheum Dis, 73, 1316, 10.1136/annrheumdis-2013-204627 Ayeldeen, 2018, Possible use of miRNAs-146a and -499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis, Mol Cell Biochem, 449, 145, 10.1007/s11010-018-3351-7 Smolen, 2016, Rheumatoid arthritis, Lancet, 388, 2023, 10.1016/S0140-6736(16)30173-8 Abualfadl, 2020, ECR COVID19-Study Group. Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient, Rheumatol Int, 1, 1 Alamanos, 2006, Incidence and prevalence of rheumatoid arthritis based on the 1987 American College of Rheumatology criteria: a systematic review, Semin Arth Rheum, 36, 182, 10.1016/j.semarthrit.2006.08.006 Hegazy, 2019, Toll-like receptor (TLR9)-1486 T/C (rs187084) gene polymorphism in Egyptian patients with rheumatoid arthritis, Egyptian Rheumatologist, 41, 173, 10.1016/j.ejr.2018.10.001 Turner, 2003, The role of mannose-binding lectin in health and disease, Mol Immunol, 40, 423, 10.1016/S0161-5890(03)00155-X Runza, 2008, Ficolins: novel pattern recognition molecules of the innate immune response, Immunobiology, 213, 297, 10.1016/j.imbio.2007.10.009 Magorivska, I, Jeremic I, Herman S, Munoz LE, Bilyy R, Herrmann M. 1.58 rheumatoid factor binding is influenced by the N-Glycans of their IGG targets. Ann Rheum Dis. 2014;73(Suppl 1):A25. Harraz, 2016, Mannose binding lectin 2 promotor-221 X/Y gene polymorphism in Egyptian systemic lupus erythematosus patients, Egypt Rheumatol, 38, 301, 10.1016/j.ejr.2016.03.005 Boldt, 2010, Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes, BMC Genet, 11, 38, 10.1186/1471-2156-11-38 Troelsen, 2012, IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis, J Rheumatol, 39, 463, 10.3899/jrheum.110584 Boldt, 2012, Relevance of the lectin pathway of complement in rheumatic diseases, Adv Clin Chem, 56, 105, 10.1016/B978-0-12-394317-0.00012-1 Sato, 1997, Substances reactive with mannose-binding protein (MBP) in sera of patients with rheumatoid arthritis, Fukushima J Med Sci, 43, 99 Troelsen, 2010, Double role of mannose-binding lectin in relation to carotid intima–media thickness in patients with rheumatoid arthritis, Mol Immunol, 47, 713, 10.1016/j.molimm.2009.10.021 Saevarsdottir, 2007, Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controls, J Rheumatol, 34, 1692 Aletaha, 2010, Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 Van der Heijde, 1993, Development of a disease activity score based on judgment in clinical practice by rheumatologists, J Rheumatol, 20, 579 Guo, 2018, Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies, Bone Res, 6, 15, 10.1038/s41413-018-0016-9 Gheita, 2019, Rheumatology in Egypt: back to the future, Rheumatol Int, 39, 1, 10.1007/s00296-018-4192-0 Abdel Salam, 2020, Whole exome sequencing (WES) of methotrexate response/adverse event profile in rheumatoid arthritis patients, Egypt Rheumatol McInnes, 2011, The pathogenesis of rheumatoid arthritis, New Engl J Med, 365, 2205, 10.1056/NEJMra1004965 Eisen, 2003, Impact of mannose-binding lectin on susceptibility to infectious diseases, Clin Infect Dis, 37, 1496, 10.1086/379324 Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T, Ohtani K, et al. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjögren’s syndrome. Genes Immun 200;2(2):99–104. Kerboua, 2016, The alternative complement pathway activity may depend on plasma malondialdehyde level in systemic lupus erythematosus patients: Preliminary results, Egypt Rheumatol, 38, 183, 10.1016/j.ejr.2016.02.003 Harraz, 2016, Mannose binding lectin 2 promotor-221 X/Y gene polymorphism in Egyptian systemic lupus erythematosus patients, Egypt Rheumatol, 38, 301, 10.1016/j.ejr.2016.03.005 Okroj, 2007, Rheumatoid arthritis and the complement system, Ann Med, 39, 517, 10.1080/07853890701477546 Goeldner, 2014, Mannose binding lectin and susceptibility to rheumatoid arthritis in Brazilian patients and their relatives, PLoS ONE, 9, 10.1371/journal.pone.0095519 Monticielo, 2010, Mannose-binding lectin gene polymorphisms in Brazilian patients with systemic lupus erythematosus, Lupus, 19, 280, 10.1177/0961203309351895 Saevarsdottir, 2011, Mannan Binding Lectin (MBL) genotypes coding for high MBL serum levels are associated with rheumatoid factor negative rheumatoid arthritis in never smokers, Arthritis Res Ther, 13, R65, 10.1186/ar3321 Song, 2014, Meta-analysis of functional MBL polymorphisms, Z Rheumatol, 73, 657, 10.1007/s00393-014-1408-x Boschmann, 2016, Mannose-binding lectin polymorphisms and rheumatoid arthritis: a short review and meta-analysis, Mol Immunol, 69, 77, 10.1016/j.molimm.2015.10.010 Xie, 2012, Association of MIF− 173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: a meta-analysis, Hum Immunol, 73, 966, 10.1016/j.humimm.2012.07.043 Allam, 2019, Clinical significance of serum B cell chemokine (CXCL13) in early rheumatoid arthritis patients, Egypt Rheumatol, 41, 11, 10.1016/j.ejr.2018.04.003